Corps Capital Advisors’s Abbott ABT Stock Holding History

Corps Capital Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,201	Closed	-$690K	–	53
2025 Q1	$690K	Hold	5,201	–	–	0.73%	43
2024 Q4	$588K	Buy	+5,201	New	+$601K	0.6%	46

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Corps Capital Advisors's ABT Position: Q2 2025 in Review

Corps Capital Advisors sold out of Abbott (ABT) in Q2 2025, closing a stake of 5,201 shares — an estimated $690K sold.

Corps Capital Advisors first reported a position in ABT in Q4 2024 and held it in 2 quarters. The position peaked at $690K in Q1 2025. 3,185 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

Corps Capital Advisors reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
Corps Capital Advisors sold 5,201 Abbott shares in Q2 2025, an estimated $690K.
Corps Capital Advisors first reported a position in Abbott in Q4 2024 and held it in 2 quarters.
Corps Capital Advisors's Abbott position peaked at $690K in Q1 2025.
3,185 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Corps Capital Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.